Patents Assigned to AstrZenca AB
  • Substituted quinolines as antitumor agents
    Patent number: 7402583
    Abstract: The invention provides a compound of Formula (Ia), or a pharmaceutically acceptable salt thereof, a process for t he preparation of a compound of Formula (1a) and pharmaceutical compositions of a compound of Formula (1a).
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: July 22, 2008
    Assignee: AstrZenca AB
    Inventors: Francis Thomas Boyle, Keith Hopkinson Gibson, Kevin Michael Foote